InfuSystem (NYSE: INFU) net income
InfuSystem reported a net profit of $6.6m for fiscal 2025, 182.6% more than in fiscal 2024 ($2.3m). Its net margin was 4.6%. Earnings per share were $0.32.
InfuSystem has grown its net income for 3 years in a row, and its best year of the last 10 was fiscal 2020. The biggest drop was in fiscal 2022, −98.7%. It reported a loss in 3 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $6.6m | +182.6% | 4.6% | $0.32 |
| 2024 | $2.3m | +168.9% | 1.7% | $0.11 |
| 2023 | $0.9m | +4,744.4% | 0.7% | $0.04 |
| 2022 | $0.0m | −98.7% | 0.0% | $0.00 |
| 2021 | $1.4m | −91.8% | 1.4% | $0.07 |
| 2020 | $17.3m | +1,173.5% | 17.8% | $0.86 |
| 2019 | $1.4m | — | 1.7% | $0.07 |
| 2018 | −$1.1m | — | −1.6% | −$0.05 |
| 2017 | −$20.7m | — | −29.1% | −$0.91 |
| 2016 | −$0.2m | — | −0.3% | −$0.01 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
InfuSystem net income compared with its sector
By net income for its latest fiscal year, InfuSystem ranks 165th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of InfuSystem, 4.6%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 163rd | LifeStance Health Group | $9.7m | 0.7% |
| 164th | Pacira Biosciences | $7.0m | 1.0% |
| 165th | InfuSystem | $6.6m | 4.6% |
| 166th | MannKind | $5.9m | 1.7% |
| 167th | Delcath Systems | $2.7m | 3.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of InfuSystem
- How much did InfuSystem earn in fiscal 2025?
- InfuSystem reported a net profit of $6.6m for fiscal 2025. In fiscal 2024 it reported a net profit of $2.3m.
- What are the earnings per share of InfuSystem?
- They were $0.32 in fiscal 2025, compared with $0.11 in fiscal 2024.
- What is the net margin of InfuSystem?
- In fiscal 2025 its net profit was 4.6% of its revenue.
- What was the most profitable year for InfuSystem?
- Of its last 10 fiscal years, fiscal 2020, with $17.3m.
- Where does InfuSystem rank in its sector by net income?
- It ranks 165th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for InfuSystem come from?
- From the annual report (Form 10-K) that InfuSystem files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that InfuSystem files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on InfuSystem: the InfuSystem page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.